Controlling neuroinflammation in Alzheimers Disease

控制阿尔茨海默病的神经炎症

• 批准号: nhmrc : 1044714
• 负责人: A/Pr Peter Crack
• 金额: $ 42.65万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 2015-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/controlling-neuroinflammation-alzheimers-disease/111683
• 关键词: Controlling; neuroinflammation; Alzheimers; Disease

Alzheimer’s disease (AD) is the most common neurodegenerative disorder worldwide, with 269,000 Australians currently diagnosed with AD and is expected to soar to about 981,000 by 2050. AD accounts for greater than 60% of all cases of dementia. This grant investigates the role that neuroinflammation plays in the progression and exacerbation of AD and will identify new therapeutic strategies to combat this insidious disease.

阿尔茨海默病（AD）是全球最常见的神经退行性疾病，目前有269，000名澳大利亚人被诊断患有AD，预计到2050年将飙升至约981，000人。AD占所有痴呆症病例的60%以上。这项资助调查了神经炎症在AD进展和恶化中的作用，并将确定新的治疗策略来对抗这种阴险的疾病。